316. Litvan I. Clinical research criteria for diagnosis of progressive supranuclear palsy // Neurology. – 1996. – V. 47. – № 1. – P. 1–9.
317. Lockwood K. A., Alexopoulos G. S., Kakuma T., Van Gorp W. G. Subtypes of cognitive im pairment in depressed older adults // Am. J. Geriatr. Psychiatry. – 2000. – V. 8. – №. 3. – P. 201–208.
318. Lovenstone S. S. Gauthier. Management of dementia. – London: Martin Dunitz, 2001. – 168 p.
319. Maddocks I., Brew B., Waddy H., Williams. Palliative neurology. Cambridge, NY.: University Press. – 260 p.
320. Mallal S., Phillips E., Carosi G. et al. HLA-B*5701 screening for hypersensitivity to abacavir // N. Engl. J. Med. – 2008. – V. 358. – № 6. – P. 568–579.
321. Maloney E. L. An Appraisal of «Chronic Lyme disease» // N. Engl. J. Med. – 2008. – V. 358. – № 4. – P. 428.
322. Marlow N., Wolke D., Bracewell M. A Neurological and developmental disability at six years of age after extremely preterm birth // N. Engl. J. Med. – 2005. – V. 352. – № 1. – P. 9–19.
323. Martin G. The effect of food odour on the human brain // Proc. Brit Psychol Soc. – 1997. – V. 5. – № 1. – P. 57.
324. Martin M., Schelling H. R. Demenz in Schlusselbegriffen. – Bern: Verlag Hans Huber, 2005. – 283 p.
325. Maurer K., Volk S., Gerbaldo H. Auguste D and Alzheimers disease // Lancet. – 1997. – V. 349. – № 9064. – P. 1546–1549.
326. Meyer J. H., Ginovart N., Boovariwala A. et al. Elevated monoamine oxidase A levels in the brain // Arch Gen Psychiatry. – 2006. – V. 63. – № 6. – P. 1209–1216.
327. Meyer T W, Hostetter T. H. Uremia // N Ehgl J Med. – 2007. – V. 357. – P. 1316–1325.
328. Miller D. H., Leary S. M. Primary-progressive multiple sclerosis // Lancet Neurology. – 2007. – V. 6. – № 10. – P. 903–912.
329. Miyoshi N., Kazui H., Ogino A. et al. Association between cognitive impairment and gait disturbance in patients with INPH // Dement Geriatr Cogn Disord. – 2005. – V. 20. – № 1. – P. 71–76.
330. Mogilnaya V. I., Litvinenko I. V., Sologub O. S. Hyperhomocysteinemia in Parkinson’s disease // Neurodegenerative Dis. – 2007. – V. 4 (Suppl 1). – P. 55.
331. Mosley R. L., Benner E. J., Kadiu I. et al. Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson’s Disease // Clin Neurosci Res. – 2006. – № 5. – P. 281.
332. Naarding P., de Koning I., dan Kooten F. et al. Depression in vascular dementia // Int. J. Geriatr. Psychiatry. – 2003. – V. 18. – № 2. – P. 325–330.
333. Neary D., Snowden J. S., Gustafson I. et al. Frontotemporal lobar degeneration // Neurology. – 1998. – V. 51. – № 6. – P. 1546–1554.
334. Nosarti C., Giouroukou E., Micali N. et al. Impaired executive functioning in young adults born very preterm // J. Int. Neuropsychol. Soc. – 2007. – V. 13. – № 4. – P. 571–581.
335. Orgogozo J. M., Gaichies S., Dartigues J. F. Influence of behavioural symptoms on resourse use // Neurodegenerative Dis.4 (Suppl 1). – 2007. – P. 51.
336. Ott A., Stolk R. P., van Harskamp F. et al. Diabetes mellitus and the risk of dementia // Neurology. – 1999. – V. 53. – № 10. – P. 1937–1942.
337. Pacher P., Beckman J. S., Liaudet L. Nitric Oxide and Peroxynitrite in Health and Disease // Physiol Rev. – 2007. – V. 87. – № 1. – P. 315–424.
338. Paraskevas K. I., Mikhailidis D. P., Liapis C. D. Internal carotid artery occlusion: association with atherosclerotic disease in other arterial beds and vascular risk factors // Angiology. – 2007. – V. 58. – № 3. – P. 329–335.
339. Park K. W., Roh J. H., Koh S. B., Lee D. H. The characteristics of cognitive impairment in Parkinson disease // Neurodegenerative Dis.4 (Suppl 1). – 2007. – P. 291.
340. Parkinsons disease: genetics and pathogenesis. ed. T. M. Dawson. In-forma Healthcare. – 2007. – USS24995. – 392 p.
341. Pelliccia A., Di Paolo F. M., Quattrini F.M. et al. Outcomes in athletes with marked ECG repolarization abnormalities // N. Engl. J. Med. – 2008. – V. 358. – № 2. – P. 152–161.
342. Petersen R. C., Doody R., Kurz A. et al. Current concepts in mild cognitive impairment // Arch. Neurol. – 2001. – V. 58. – № 9. – P. 1985–1992.
